On 2025-05-14, Unicycive Therapeutics, Inc. (UNCY) announced earnings per share of $-0.05 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.08.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.07 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
---|---|---|---|
2025-05-14 | 2025-03-31 | $-0.08 | $-0.05 |
2025-03-31 | 2024-12-31 | $-0.13 | $-0.26 |
2024-11-13 | 2024-09-30 | $-0.13 | $-0.05 |
2024-08-14 | 2024-06-30 | $-0.23 | $-0.15 |
2024-05-13 | 2024-03-31 | $-0.18 | $-0.27 |
2024-03-28 | 2023-12-31 | $-0.18 | $-0.16 |
2023-11-14 | 2023-09-30 | $-0.13 | $-0.13 |
2023-08-14 | 2023-06-30 | $-0.39 | $-0.29 |
2023-05-16 | 2023-03-31 | $-0.36 | $-0.29 |
2023-03-31 | 2022-12-31 | -- | $-0.35 |
2022-11-14 | 2022-09-30 | $-0.35 | $-0.37 |
2022-08-15 | 2022-06-30 | $-0.27 | $-0.24 |
2022-05-12 | 2022-03-31 | $-0.20 | $-0.24 |
2022-03-31 | 2021-12-31 | -- | $-0.17 |
2021-11-11 | 2021-09-30 | $-0.11 | $-0.37 |
2021-08-16 | 2021-06-30 | $-0.11 | $-0.13 |